Intervention Study on Weight Loss in Patients With Obesity

NCT ID: NCT07124832

Last Updated: 2025-08-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-08-14

Study Completion Date

2025-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to evaluate the feasibility of using Socratic questioning as an alternative method for weight loss in adult patients with obesity (aged 18 to 65) in a primary care setting.

The main question it aims to answer is:

-Is Socratic questioning an effective alternative approach for promoting weight loss in patients with obesity?

Researchers will compare participants receiving Socratic questioning during follow-up visits with those receiving regular care to see if the intervention leads to greater weight loss.

Participants will:

* Complete a baseline questionnaire including 9 demographic questions and the 14-item Hospital Anxiety and Depression Scale (approx. 5 minutes).
* Attend five in-person follow-up visits with their family physician over a 3-month period (every 15 or 30 days), where they will receive brief counseling (10-15 minutes per visit) and have their weight, height, and waist circumference measured.
* Complete a 17-question final questionnaire at the end of 3 months (approx. 10-15 minutes).
* Be referred to mental health services if necessary, based on initial screening results.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Work Packages:

1. Providing training to physicians on Socratic questioning:

Training will be delivered online by an instructor experienced in cognitive behavioral therapy.
2. Recruitment of patients:

During routine outpatient visits, physicians will assess patients diagnosed with obesity according to inclusion and exclusion criteria. Eligible patients will be recruited after providing informed consent. Patients will complete an information form and the Hospital Anxiety and Depression Scale (HADS). Those with significant psychopathology will be referred to a specialist for psychiatric evaluation. A first appointment (Day 0) will be scheduled.
3. Group allocation:

After recruiting a patient, the physician will contact the research team to learn the patient's group assignment. The physician will be informed about the assigned group. Group allocation will be based on a pre-prepared list using computer-assisted block randomization.
4. Recording group assignment in the health information system:

The patient's assigned group will be recorded in the Family Medicine Information System, and a reminder note will be visible during each consultation.
5. Physician-patient consultation on Day 0:

The physician will take measurements and provide counseling about obesity. In the intervention group, the physician will apply the Socratic questioning technique. In the control group, the physician will follow routine obesity management practices. The next appointment (Day 15) will be scheduled.
6. Physician-patient consultation on Day 15:

The physician will provide counseling about obesity. No measurements will be taken at this visit. The next appointment (Day 30) will be scheduled.
7. Physician-patient consultation on Day 30:

The physician will provide counseling and take measurements. The next appointment (Day 60) will be scheduled.
8. Physician-patient consultation on Day 60:

The physician will provide counseling and take measurements. The next appointment (Day 90) will be scheduled.
9. Physician-patient consultation on Day 90:

Final measurements will be taken, and the study participation will be completed.
10. Data analysis:

Physicians will share the collected data with the research team. The data from this pilot study will be analyzed.
11. Process evaluation:

At the end of the study, surveys including Likert-scale, multiple-choice, and open-ended questions will be administered to physicians and patients in the intervention group by the research team.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants will be assigned to intervention and control groups at a 1:1 ratio using the block randomization method (block size 6) with a computer-aided program.
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Socratic Questioning Group

Participants in the intervention group will be followed up by physicians using the Socratic questioning technique. Face-to-face meetings will be held on the 0th, 15th, 30th and 60th days, and each session will take approximately 10-15 minutes. Physicians will use a checklist and ICD-10 code (E66: Obesity) when recording participant notes. The group to which the participant is assigned will be indicated in the Family Medicine Information System, and this warning note will be visible to physicians at each examination. Researchers will not interfere with the content of the interview, and physicians will be given flexibility to apply the Socratic questioning technique according to the needs of the participant.

Group Type ACTIVE_COMPARATOR

Socratic Questioning Method

Intervention Type BEHAVIORAL

Socratic questioning is a method in which behaviour is examined through questions such as "what, where, which, who, when, how, and why". It consists of four stages: defining the problem, evaluating and identifying alternatives, redefining, and discussing feasible outcomes. Through this process, individuals develop their critical thinking skills and make self-evaluations.

Regular Care Group

Participants in the control group will be followed up with the routine obesity approach used by physicians in their daily practice. Physicians will maintain the standard of care they normally give to patients with obesity. This approach may include nutritional advice, physical activity recommendations, and general lifestyle change advice, but Socratic questioning techniques will not be used.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Socratic Questioning Method

Socratic questioning is a method in which behaviour is examined through questions such as "what, where, which, who, when, how, and why". It consists of four stages: defining the problem, evaluating and identifying alternatives, redefining, and discussing feasible outcomes. Through this process, individuals develop their critical thinking skills and make self-evaluations.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age between 18 and 65 years
* Body Mass Index (BMI) ≥ 30 kg/m²
* Willingness to participate in the study

Exclusion Criteria

* Pregnancy or breastfeeding
* Presence of active psychosis or manic episode
* Intellectual disability
* Severe depression or personality disorder
* Auto- or hetero-aggressive behavior
* Reported use of psychoactive substances
* Suicidal ideation
* Participation in another weight loss program within the last 6 months
* Use of medications that cause long-term weight gain or loss
* Detection of psychopathology based on the Hospital Anxiety and Depression Scale (HADS)
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sıdıka Ece Yokuş

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sıdıka Ece Yokuş

Research Assistant

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Raquel Gómez Bravo

Role: STUDY_DIRECTOR

Centre Hospitalier Neuro-Psychiatrique, Luxembourg

Vinicius Anjos de Almeida

Role: STUDY_DIRECTOR

University of São Paulo, Brazil

Sandra León Herrera

Role: STUDY_DIRECTOR

University of Zaragoza, Spain

Sıdıka E. Yokuş

Role: PRINCIPAL_INVESTIGATOR

Manisa Celal Bayar University

Hüseyin Elbi

Role: STUDY_DIRECTOR

Manisa Celal Bayar University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Manisa Celal Bayar University Mustafa Yardimci Education Family Health Center

Manisa, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sıdıka E. Yokuş

Role: CONTACT

+905070615616

Hüseyin Elbi

Role: CONTACT

+905055569911

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sıdıka E. Yokuş

Role: primary

+905070615616

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20.478.486/3150

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.